Detailed information for compound 17603

Basic information

Technical information
  • TDR Targets ID: 17603
  • Name: (3S,6S,9S,12R)-3-butan-2-yl-6-(1-methoxy-4-ox oquinolin-3-yl)-9-(6-oxooctyl)-1,4,7,10-tetra zabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
  • MW: 637.766 | Formula: C34H47N5O7
  • H donors: 3 H acceptors: 6 LogP: 3.47 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCC(=O)CCCCC[C@@H]1NC(=O)[C@@H]2CCCCN2C(=O)[C@@H](NC(=O)[C@@H](NC1=O)c1cn(OC)c2c(c1=O)cccc2)[C@H](CC)C
  • InChi: 1S/C34H47N5O7/c1-5-21(3)28-34(45)38-19-13-12-18-27(38)32(43)35-25(16-9-7-8-14-22(40)6-2)31(42)37-29(33(44)36-28)24-20-39(46-4)26-17-11-10-15-23(26)30(24)41/h10-11,15,17,20-21,25,27-29H,5-9,12-14,16,18-19H2,1-4H3,(H,35,43)(H,36,44)(H,37,42)/t21?,25-,27+,28-,29-/m0/s1
  • InChiKey: IEVZGTIIJVLPRE-RYADJZTKSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • (3S,6S,9S,12R)-6-(1-methoxy-4-oxo-3-quinolyl)-9-(6-oxooctyl)-3-sec-butyl-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
  • (3S,6S,9S,12R)-3-butan-2-yl-6-(1-methoxy-4-oxo-quinolin-3-yl)-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
  • (3S,6S,9S,12R)-6-(4-keto-1-methoxy-3-quinolyl)-9-(6-ketooctyl)-3-sec-butyl-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-diquinone

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni histone deacetylase hda2 0.019 0.3571 0.3571
Trypanosoma cruzi histone deacetylase, putative 0.0377 0.7949 0.7542
Loa Loa (eye worm) histone deacetylase 3 0.0465 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.005 0.03 0.03
Trichomonas vaginalis histone deacetylase, putative 0.0465 1 1
Brugia malayi histone deacetylase 1 (HD1) 0.0465 1 1
Echinococcus granulosus histone deacetylase 0.0377 0.7949 0.7885
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.005 0.03 0.03
Echinococcus multilocularis histone deacetylase 7 0.0377 0.7949 0.7885
Echinococcus granulosus mitogen activated protein kinase 0.0108 0.1654 0.1396
Trypanosoma brucei histone deacetylase, putative 0.0377 0.7949 0.7542
Echinococcus granulosus histone deacetylase 6 0.0377 0.7949 0.7885
Trichomonas vaginalis histone deacetylase, putative 0.0465 1 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.005 0.03 0.03
Loa Loa (eye worm) histone deacetylase 0.0377 0.7949 0.7949
Brugia malayi histone deacetylase 11 0.019 0.3571 0.3571
Plasmodium vivax histone deacetylase, putative 0.0377 0.7949 0.681
Trichomonas vaginalis histone deacetylase, putative 0.0465 1 1
Trichomonas vaginalis histone deacetylase 1, 2 ,3, putative 0.0465 1 1
Echinococcus granulosus histone deacetylase 3 0.0465 1 1
Plasmodium falciparum histone deacetylase 1 0.0465 1 1
Brugia malayi Histone deacetylase family protein 0.0377 0.7949 0.7949
Toxoplasma gondii histone deacetylase HDAC3 0.0465 1 1
Trichomonas vaginalis histone deacetylase 1, 2 ,3, putative 0.0465 1 1
Trichomonas vaginalis histone deacetylase, putative 0.0465 1 1
Loa Loa (eye worm) hypothetical protein 0.019 0.3571 0.3571
Toxoplasma gondii histone deacetylase HDAC4 0.019 0.3571 0.2296
Echinococcus granulosus histone deacetylase 6 0.0385 0.8123 0.8065
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0055 0.0406 0.0406
Echinococcus granulosus histone deacetylase 8 0.019 0.3571 0.3371
Leishmania major histone deacetylase, putative 0.0377 0.7949 0.7542
Trypanosoma brucei histone deacetylase 3 0.0377 0.7949 0.7542
Echinococcus granulosus histone deacetylase 1 0.0465 1 1
Schistosoma mansoni histone deacetylase 4 5 0.0377 0.7949 0.7949
Echinococcus multilocularis histone deacetylase 3 0.0465 1 1
Toxoplasma gondii histone deacetylase HDAC2 0.0465 1 1
Trypanosoma cruzi histone deacetylase, putative 0.0377 0.7949 0.7542
Trichomonas vaginalis histone deacetylase 1, 2 ,3, putative 0.0465 1 1
Loa Loa (eye worm) histone deacetylase 1 0.0465 1 1
Echinococcus multilocularis mitogen activated protein kinase 0.0108 0.1654 0.1396
Schistosoma mansoni histone deacetylase 0.0465 1 1
Toxoplasma gondii histone deacetylase HDAC5 0.019 0.3571 0.2296
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.005 0.03 0.03
Echinococcus multilocularis histone deacetylase 1 0.0465 1 1
Echinococcus granulosus histone deacetylase 7 0.0377 0.7949 0.7885
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.0108 0.1654 0.1654
Toxoplasma gondii histone deacetylase HDAC1 0.0377 0.7949 0.7542
Trypanosoma brucei histone deacetylase 4 0.0377 0.7949 0.7542
Loa Loa (eye worm) histone deacetylase 7A 0.0377 0.7949 0.7949
Schistosoma mansoni histone deacetylase 0.0465 1 1
Echinococcus multilocularis histone deacetylase 6 0.0377 0.7949 0.7885
Loa Loa (eye worm) hypothetical protein 0.0055 0.0406 0.0406
Brugia malayi Histone deacetylase family protein 0.0377 0.7949 0.7949
Trypanosoma cruzi histone deacetylase, putative 0.019 0.3571 0.2296
Leishmania major histone deacetylase, putative 0.0465 1 1
Echinococcus multilocularis histone deacetylase 6 0.0377 0.7949 0.7885
Trypanosoma cruzi histone deacetylase 1, putative 0.0465 1 1
Brugia malayi MAP kinase sur-1 0.0108 0.1654 0.1654
Trypanosoma cruzi histone deacetylase 1, putative 0.0465 1 1
Loa Loa (eye worm) histone deacetylase 11 0.019 0.3571 0.3571
Plasmodium vivax histone deacetylase 2, putative 0.0377 0.7949 0.681
Trypanosoma brucei histone deacetylase 2 0.019 0.3571 0.2296
Trypanosoma brucei histone deacetylase 1 0.0465 1 1
Trichomonas vaginalis histone deacetylase, putative 0.0465 1 1
Schistosoma mansoni histone deacetylase 4 5 0.0377 0.7949 0.7949
Brugia malayi Histone deacetylase 1 0.0465 1 1
Giardia lamblia Histone deacetylase 0.0465 1 1
Echinococcus multilocularis histone deacetylase 8 0.019 0.3571 0.3371
Trypanosoma cruzi histone deacetylase, putative 0.019 0.3571 0.2296
Onchocerca volvulus Histone deacetylase 10 homolog 0.019 0.3571 0.5
Leishmania major histone deacetylase, putative 0.0377 0.7949 0.7542
Echinococcus multilocularis histone deacetylase 0.0377 0.7949 0.7885
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0055 0.0406 0.0406
Trichomonas vaginalis histone deacetylase, putative 0.0465 1 1
Echinococcus granulosus mitogen activated protein kinase 3 0.0108 0.1654 0.1396
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.005 0.03 0.03
Plasmodium vivax histone deacetylase 1, putative 0.0465 1 1
Echinococcus multilocularis histone deacetylase 6 0.0385 0.8123 0.8065
Loa Loa (eye worm) hypothetical protein 0.0195 0.3675 0.3675
Schistosoma mansoni histone deacetylase 1 2 3 0.019 0.3571 0.3571
Echinococcus multilocularis mitogen activated protein kinase 3 0.0108 0.1654 0.1396
Schistosoma mansoni histone deacetylase hda2 0.0385 0.8123 0.8123
Entamoeba histolytica histone deacetylase, putative 0.0465 1 0.5
Leishmania major histone deacetylase, putative 0.0465 1 1
Echinococcus granulosus histone deacetylase 6 0.0377 0.7949 0.7885
Loa Loa (eye worm) hypothetical protein 0.0187 0.3501 0.3501
Trypanosoma cruzi histone deacetylase, putative 0.0377 0.7949 0.7542
Schistosoma mansoni serine/threonine protein kinase 0.0108 0.1654 0.1654
Loa Loa (eye worm) hypothetical protein 0.0465 1 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.0055 0.0406 0.0406

Activities

Activity type Activity value Assay description Source Reference
AP50 (functional) = 10000 ng ml-1 Tested in vitro by mammalian antiproliferative functional assay using human HeLa cells or foreskin fibroblasts ChEMBL. 11206439
AP50 (functional) = 10000 ng ml-1 Tested for mammalian cell (HeLa)-based antiproliferative assay ChEMBL. 11124001
IC50 (functional) = 40 ng ml-1 In vitro antiprotozoal activity using whole red blood cells infected with Plasmodium falciparum ChEMBL. 11206439
IC50 (binding) = 40 ng ml-1 Displacement of [3H]-Apicidin A from Histone deacetylase of E. tenella extract ChEMBL. 11124001
IC50 (functional) = 40 ng ml-1 Tested for parasite (malaria)-based antiproliferative assay ChEMBL. 11124001
IC50 (binding) = 1000 ng ml-1 Inhibition of [3H]-Apicidin A binding to Histone deacetylase of chick liver extract ChEMBL. 11124001
IC50 (binding) = 3.8 nM Tested for Histone deacetylase enzyme inhibition assay using E. tenella extract ChEMBL. 11124001
IC50 (binding) = 4 nM Inhibitory activity against histone deacetylase enzyme derived from partially purified extracts of Eimeria tenella protozoa using [3H]-11 as radioligand ChEMBL. 11206439
IC50 (binding) = 86 nM Inhibitory activity against histone deacetylase (HDAC) enzyme derived from partially purified extracts of human HeLa cells using [3H]-11 as radioligand ChEMBL. 11206439
IC50 (binding) = 86 nM Tested for Histone deacetylase enzyme inhibition assay using mammalian cell nuclear extract (HeLa) ChEMBL. 11124001
Ki (binding) = 30 nM Binding affinity towards HDAC enzyme derived from Eimeria tenella protozoa ChEMBL. 11206439
Ki (binding) = 1500 nM Binding affinity towards HDAC enzyme derived from chicken liver (CL) cells ChEMBL. 11206439
MIC (functional) = 250 ng ml-1 In vitro antiprotozoal activity using Mauden-Downing bovine kidney host cells infected with Eimeria tenella ChEMBL. 11206439

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.